Protein A Resin Market

Protein A Resin Market by Product (Agarose-based, Glass/Silica-based), Type (Recombinant Protein A, Natural Protein A), Application (Antibody Purification, Immunoprecipitation), End User & Region - Global Forecast to 2025

Report Code: AST 7818 Jan, 2021, by marketsandmarkets.com

Updated on : February 07, 2023

The global protein A resin market in terms of revenue was estimated to be worth $1.1 billion in 2020 and is poised to reach $1.9 billion by 2025, growing at a CAGR of 11.4% from 2020 to 2025. The growth in this market is mainly driven by the growing demand for disposable pre-packed columns, the increasing demand for therapeutic antibodies, and the increasing pharmaceutical R&D spending that is expected to drive the growth of this market during the forecast period. However, the high cost of resins is expected to limit the growth of this market.

Protein A Resin Market

To know about the assumptions considered for the study, Request for Free Sample Report

Protein A Resin Market Dynamics

Driver: Increasing demand for therapeutic antibodies

Chromatography is an essential step in the purification of monoclonal antibodies (mAbs). Over the past decade, there has been a tremendous increase in the demand for monoclonal antibodies in oncology and several other therapeutic areas, including neurological, autoimmune, and inflammatory disorders. As a result, almost all major pharmaceutical companies are focusing on the R&D of therapeutic antibodies.

In the purification of monoclonal antibodies, anionic impurities, such as nucleic acids and endotoxins, are removed through chromatography. In drug discovery applications, this process consumes a large amount of resin, as the usage is not limited to purification but also includes the study of the ionic interactions of molecules. Impurities such as albumin and transferrin are removed by size-exclusion chromatography (SEC). High levels of purification can be achieved through the use of protein-A affinity resins. This is because antibodies selectively bind protein A ligands to the resins. This is expected to drive the demand for protein A resins during the forecast period.

Restrain: high cost of resins

Protein A resins cost around 5–10 times more than other types of resin. Though there are no alternative techniques that can achieve purification levels as high as protein A resins, their high cost makes end users look for alternatives. Some of the techniques that provide acceptable levels of purification include both chromatography and non-chromatography methods. mAb crystallisation and precipitation by polyethylene glycol (PEG) precipitation are being explored as alternatives for protein A chromatography.

This restraining factor has a greater impact in emerging markets such as APAC and Latin America. However, with the entry of new market players, the cost of protein A resins is expected to come down significantly. The increasing pressure on major market players is expected to result in price reductions, as small market entrants are offering resins at far lower prices while simultaneously offering comparable product quality.

Opportunity: An increasing number of CMOs and CROs

An increasing number of CMOs and CROs are offering their services to pharmaceutical companies across the globe. This is expected to offer potential growth opportunities to protein A resin manufacturers during the forecast period.

Pharmaceutical companies are increasingly relying on contract manufacturers in various areas of research to fulfil a number of basic needs, such as specialised competencies and cost reduction. The pharmaceutical contract manufacturing industry has experienced robust growth in recent years, and this trend is expected to continue in the coming years. The increasing pressure from several governments to reduce healthcare costs and declining R&D productivity have compelled core pharmaceutical producers to rely on contract manufacturing. Moreover, the rising demand for generic drugs in China and India is a key driver for CMO sales.

The agarose-based segment is expected to command the largest share of protein A resin market.

Based on product, the market is segmented into agarose-based protein A, glass/silica-based protein A, and organic polymer-based protein A. The large share of this segment can be attributed to agarose being the most widely used matrix resin for the attachment of ligands that bind proteins.

The antibody purification segment is expected to command the largest share of protein A resin market.

Based on application, the market is segmented into antibody purification and immunoprecipitation. The large share of this segment can primarily be attributed to the increasing demand for monoclonal antibodies for therapeutic as well as research purposes, which has driven the demand for protein A resins used in the downstream processing of these antibodies.

Pharmaceutical and biopharmaceutical companies account for the majority of the protein A resin market.

Based on end users, the market is segmented into pharmaceutical and biopharmaceutical companies, academic research institutes, and other end users. The increasing R&D expenditure of pharmaceutical and biopharmaceutical companies is the primary driver of this end-user segment's growth.

North America is expected to dominate the protein A resin market during the forecast period

Geographically, North America is expected to dominate the global market in 2019, while the Asia-Pacific region is expected to register the highest CAGR during the forecast period. The increased R&D activities in this region can be attributed to the region's rapid growth, as APAC has emerged as a key pharmaceutical and biopharmaceutical research hub. Considering this, a number of key pharmaceutical and biopharmaceutical companies have set up their research centres in the region. Also, local major players such as Ranbaxy, Dr. Reddy's, Cipla, Lupin, and Cadila are actively involved in research on biosimilars and generic drugs.

Protein A Resin Market by Region

GE Healthcare (US), Repligen Corporation (US), and Merck Millipore (Germany) are some of the leading players in the protein A resin market.

Protein A Resin Market Report Scope

Report Metric

Details

Market Revenue in 2020

$1.1 billion

Estimated Value by 2025

$1.9 billion

Growth Rate

Poised to grow at a CAGR of 11.4%

Geographies covered

North America (US & Canada), Europe (Germany, UK, France, Italy, Spain, RoE), Asia Pacific (China, Japan, India, RoAPAC), and RoW

Companies covered

Major 20 players included, including GE Healthcare (US), Merck Millipore (Germany), Repligen Corporation (US), Thermo Fisher Scientific (US), Tosoh Bioscience (Japan), Purolite Corporation (US), Novasep Holding SAS (France), Agilent Technologies (US), GenScript Biotech Corporation (China), PerkinElmer (US), Bio-Rad Laboratories (US), Orochem (US), Kaneka Corporation (Japan), Abcam (UK), Agarose Bead Technologies (US), Avantor (US), JSR Life Sciences (US), Bio-Works Technologies (Sweden), Amikozen Co. Ltd. (US), and Takara Bio Inc. (Japan).

This research report categorizes the protein A ?resin market based on product, type, application, end user, and region.

By Product

  • Agarose-based Protein A
  • Glass/Silica-based Protein A
  • Organic Polymer-based Protein A

By Type

  • Recombinant Protein A
  • Natural Protein A

By Application

  • Antibody Purification
  • Immunoprecipitation

By End-User

  • Pharmaceutical & Biopharmaceutical Companies
  • Academic Research Institutes
  • Other End Users

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • RoE
  • Asia Pacific
    • China
    • Japan
    • India
    • RoAPAC
  • RoW

Recent Developments

  • In 2018, Merck Millipore (Germany) opened a new manufacturing and distribution center in India for its Life Science business.
  • In 2017, Repligen Corporation (US) merged with Spectrum Inc. (US), a leader in membrane separation technologies for the pharmaceutical, bioprocess, diagnostic, and research industries. This merger was aimed at accelerating the growth of its filtration business and enhancing its position as a leading developer of single-use and continuous manufacturing technologies for bioprocessing.
  • In 2017, Purolite Life Sciences collaborated with ChromaTan Corporation (US), which provides chromatography solutions. The development increased the production of protein A resins by up to 15 times.

Frequently Asked Questions (FAQs):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 20)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
    1.3 INCLUSIONS AND EXCLUSIONS
           1.3.1 MARKETS COVERED
           FIGURE 1 PROTEIN A RESIN MARKET SEGMENTATION
           1.3.2 YEARS CONSIDERED FOR THE REPORT
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. - 23)
    2.1 RESEARCH DATA
    2.2 RESEARCH METHODOLOGY STEPS
           FIGURE 2 RESEARCH METHODOLOGY: GLOBAL MARKET
           FIGURE 3 RESEARCH DESIGN
           2.2.1 SECONDARY DATA
                    2.2.1.1 Key data from secondary sources
           2.2.2 PRIMARY DATA
           FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
           FIGURE 5 PRIMARY SOURCES
                    2.2.2.1 Key data from primary sources
    2.3 MARKET SIZE ESTIMATION METHODOLOGY
           FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
           FIGURE 7 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
    2.4 MARKET DATA ESTIMATION AND TRIANGULATION
           FIGURE 8 DATA TRIANGULATION METHODOLOGY
    2.5 ASSUMPTIONS FOR THE STUDY
    2.6 COVID-19-SPECIFIC ASSUMPTIONS

3 EXECUTIVE SUMMARY (Page No. - 32)
           FIGURE 9 GLOBAL MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
           FIGURE 10 GLOBAL MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
           FIGURE 11 GLOBAL MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
           FIGURE 12 GLOBAL MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
           FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE GLOBAL MARKET

4 PREMIUM INSIGHTS (Page No. - 36)
    4.1 GLOBAL MARKET OVERVIEW
           FIGURE 14 ADVANTAGES OF PROTEIN A RESINS HAVE DRIVEN THEIR ADOPTION
    4.2 NORTH AMERICA: MARKET, 2019
           FIGURE 15 US ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2019
    4.3 GLOBAL MARKET, BY PRODUCT & SERVICE
           FIGURE 16 AGAROSE-BASED PROTEIN A SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2020
    4.4 GLOBAL MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
           FIGURE 17 ASIA PACIFIC MARKET TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 39)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 18 GLOBAL MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
           5.2.1 DRIVERS
                    5.2.1.1 Growing demand for disposable pre-packed columns
           TABLE 1 ADVANTAGES OF PRE-PACKED COLUMNS
                    5.2.1.2 Increasing demand for therapeutic antibodies
                    5.2.1.3 Increasing pharmaceutical R&D spending
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of resins
                    5.2.2.2 Dearth of skilled professionals
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Increasing number of CMOs and CROs
           FIGURE 19 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET GROWTH, 2019–2024
                    5.2.3.2 Increasing demand for biosimilars
           FIGURE 20 GROWTH OF THE BIOSIMILARS MARKET, 2018–2023
           TABLE 2 LIST OF KEY BIOLOGICS UNDER THE THREAT OF PATENT EXPIRY
    5.3 PRICING ANALYSIS: GLOBAL MARKET
    5.4 PORTER’S FIVE FORCES ANALYSIS
           FIGURE 21 PORTER’S FIVE FORCES ANALYSIS
           5.4.1 THREAT OF SUBSTITUTES
           5.4.2 BARGAINING POWER OF SUPPLIERS
           5.4.3 BARGAINING POWER OF BUYERS
           5.4.4 THREAT OF NEW ENTRANTS
           5.4.5 INTENSITY OF COMPETITIVE RIVALRY
    5.5 IMPACT OF COVID-19 ON THE GLOBAL MARKET
    5.6 VALUE CHAIN ANALYSIS
           FIGURE 22 MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASE
           5.6.1 RESEARCH & DEVELOPMENT
           5.6.2 MANUFACTURING & ASSEMBLY
           5.6.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
    5.7 SUPPLY CHAIN ANALYSIS
           5.7.1 PROMINENT COMPANIES
           5.7.2 SMALL AND MEDIUM-SIZED ENTERPRISES
           5.7.3 END USERS
           FIGURE 23 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES
           FIGURE 24 ECOSYSTEM ANALYSIS OF THE GLOBAL MARKET

6 PROTEIN A RESIN MARKET, BY PRODUCT (Page No. - 52)
    6.1 INTRODUCTION
           TABLE 3 GLOBAL MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
    6.2 AGAROSE-BASED PROTEIN A
           6.2.1 BENEFITS OFFERED BY AGAROSE MAKES IT THE PREFERRED CHOICE FOR PROTEIN PURIFICATION
           TABLE 4 AGAROSE-BASED PROTEIN A MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 5 NORTH AMERICA: AGAROSE-BASED PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 6 EUROPE: AGAROSE-BASED PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 7 APAC: AGAROSE-BASED PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
    6.3 GLASS/SILICA-BASED PROTEIN A
           6.3.1 LOW PH TOLERANCE OF SILICA-BASED RESINS TO LIMIT THEIR MARKET GROWTH
           TABLE 8 GLASS/SILICA-BASED PROTEIN A MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 9 NORTH AMERICA: GLASS/SILICA-BASED PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 10 EUROPE: GLASS/SILICA-BASED PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 11 APAC: GLASS/SILICA-BASED PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
    6.4 ORGANIC POLYMER-BASED PROTEIN A
           6.4.1 INCREASING POPULARITY OF ORGANIC POLYMERS TO DRIVE MARKET GROWTH
           TABLE 12 ORGANIC POLYMER-BASED PROTEIN A MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 13 NORTH AMERICA: ORGANIC POLYMER-BASED PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 14 EUROPE: ORGANIC POLYMER-BASED PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 15 APAC: ORGANIC POLYMER-BASED PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)

7 PROTEIN A RESIN MARKET, BY TYPE (Page No. - 59)
    7.1 INTRODUCTION
           TABLE 16 GLOBAL MARKET, BY TYPE, 2018–2025 (USD MILLION)
    7.2 RECOMBINANT PROTEIN A
           7.2.1 COST-EFFICIENCY OF RECOMBINANT PROTEINS TO DRIVE MARKET GROWTH
           TABLE 17 RECOMBINANT PROTEIN A MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 18 NORTH AMERICA: RECOMBINANT PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 19 EUROPE: RECOMBINANT PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 20 APAC: RECOMBINANT PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
    7.3 NATURAL PROTEIN A
           7.3.1 ADVANTAGES OF RECOMBINANT PROTEIN A HAVE RESTRICTED THE MARKET POTENTIAL OF NATURAL PROTEIN A
           TABLE 21 NATURAL PROTEIN A MARKET, BY REGION, 2018–2025 (USD MILLION)
           TABLE 22 NORTH AMERICA: NATURAL PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 23 EUROPE: NATURAL PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 24 APAC: NATURAL PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)

8 PROTEIN A RESIN MARKET, BY APPLICATION (Page No. - 64)
    8.1 INTRODUCTION
           TABLE 25 GLOBAL MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
    8.2 ANTIBODY PURIFICATION
           8.2.1 ANTIBODY PURIFICATION SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
           TABLE 26 GLOBAL MARKET FOR ANTIBODY PURIFICATION, BY REGION, 2018–2025 (USD MILLION)
    8.3 IMMUNOPRECIPITATION
           8.3.1 IMMUNOPRECIPITATION SEGMENT TO GROW AT A LOWER CAGR DURING THE FORECAST PERIOD
           TABLE 27 GLOBAL MARKET FOR IMMUNOPRECIPITATION, BY REGION, 2018–2025 (USD MILLION)

9 PROTEIN A RESIN MARKET, BY END USER (Page No. - 67)
    9.1 INTRODUCTION
           TABLE 28 GLOBAL MARKET, BY END USER, 2018–2025 (USD MILLION)
    9.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
           9.2.1 PROTEIN A RESIN IS EXTENSIVELY USED TO PRODUCE BIOLOGICAL DRUGS
           FIGURE 25 SPENDING ON BIOPHARMACEUTICAL RESEARCH, 2005–2020 (USD BILLION)
           TABLE 29 GLOBAL MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018–2025 (USD MILLION)
    9.3 ACADEMIC RESEARCH INSTITUTES
           9.3.1 BOOMING R&D IN DRUG DISCOVERY LIKELY TO INCREASE THE USE OF PROTEIN A RESINS
           TABLE 30 GLOBAL MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018–2025 (USD MILLION)
    9.4 OTHER END USERS
           TABLE 31 GLOBAL MARKET FOR OTHER END USERS, BY REGION, 2018–2025 (USD MILLION)

10 PROTEIN A RESIN MARKET, BY REGION (Page No. - 71)
     10.1 INTRODUCTION
           TABLE 32 GLOBAL MARKET, BY REGION, 2018–2025 (USD MILLION)
     10.2 NORTH AMERICA
           FIGURE 26 NORTH AMERICA: MARKET SNAPSHOT
           TABLE 33 NORTH AMERICA: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 34 NORTH AMERICA: MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 35 NORTH AMERICA: MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 36 NORTH AMERICA: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 37 NORTH AMERICA: MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.2.1 US
                        10.2.1.1 Booming R&D investment in the pharmaceutical industry to propel market growth
           TABLE 38 US: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 39 US: MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 40 US: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 41 US: MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.2.2 CANADA
                        10.2.2.1 Government initiatives focused on boosting the pharmaceutical industry to drive market growth
           TABLE 42 CANADA: MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 43 CANADA: MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 44 CANADA: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 45 CANADA: MARKET, BY END USER, 2018–2025 (USD MILLION)
     10.3 EUROPE
           FIGURE 27 EUROPE: MARKET SNAPSHOT
           TABLE 46 EUROPE: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 47 EUROPE: MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 48 EUROPE: MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 49 EUROPE: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 50 EUROPE: MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.3.1 GERMANY
                        10.3.1.1 Flourishing biotechnology industry in the country to drive market growth
           TABLE 51 GERMANY: MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 52 GERMANY: MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 53 GERMANY: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 54 GERMANY: MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.3.2 UK
                        10.3.2.1 Favorable R&D scenario in the country to support market growth
           TABLE 55 UK: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 56 UK: MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 57 UK: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 58 UK: MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.3.3 FRANCE
                        10.3.3.1 Favorable healthcare scenario to boost market growth in France
           TABLE 59 FRANCE: MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 60 FRANCE: MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 61 FRANCE: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 62 FRANCE: MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.3.4 ITALY
                        10.3.4.1 Well-established pharmaceutical industry in the country to spur the demand for protein A resins
           TABLE 63 ITALY: MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 64 ITALY: MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 65 ITALY: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 66 ITALY: MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.3.5 SPAIN
                        10.3.5.1 Presence of a large number of biotech R&D service providers to support market growth
           TABLE 67 SPAIN: MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 68 SPAIN: MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 69 SPAIN: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 70 SPAIN: MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.3.6 REST OF EUROPE
           TABLE 71 ROE: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 72 ROE: MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 73 ROE: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 74 ROE: MARKET, BY END USER, 2018–2025 (USD MILLION)
     10.4 ASIA PACIFIC
           FIGURE 28 APAC: MARKET SNAPSHOT
           TABLE 75 ASIA PACIFIC: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
           TABLE 76 ASIA PACIFIC: MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 77 ASIA PACIFIC: MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 78 ASIA PACIFIC: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 79 ASIA PACIFIC: MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.4.1 JAPAN
                        10.4.1.1 Increasing demand for generic drugs and monoclonal antibody biosimilars is driving resin consumption in the country
           TABLE 80 JAPAN: MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 81 JAPAN: MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 82 JAPAN: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 83 JAPAN: MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.4.2 CHINA
                        10.4.2.1 Increased pharmaceutical R&D spending to drive market growth
           TABLE 84 CHINA: MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 85 CHINA: MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 86 CHINA: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 87 CHINA: MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.4.3 INDIA
                        10.4.3.1 Growth of the pharma and biotech industries is leading to high demand for protein A resins in India
           TABLE 88 INDIA: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 89 INDIA: MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 90 INDIA: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 91 INDIA: MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.4.4 REST OF ASIA PACIFIC
           TABLE 92 ROAPAC: MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 93 ROAPAC: MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 94 ROAPAC: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 95 ROAPAC: MARKET, BY END USER, 2018–2025 (USD MILLION)
     10.5 REST OF THE WORLD
           FIGURE 29 ROW: MARKET SNAPSHOT
           TABLE 96 ROW: MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
           TABLE 97 ROW: MARKET, BY TYPE, 2018–2025 (USD MILLION)
           TABLE 98 ROW: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
           TABLE 99 ROW: MARKET, BY END USER, 2018–2025 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 100)
     11.1 OVERVIEW
           FIGURE 30 KEY DEVELOPMENTS IN THE PROTEIN A RESIN MARKET, 2017–2019
     11.2 MARKET SHARE ANALYSIS
           FIGURE 31 GLOBAL MARKET SHARE ANALYSIS (2019)
     11.3 COMPETITIVE LEADERSHIP MAPPING
             11.3.1 VISIONARY LEADERS
             11.3.2 INNOVATORS
             11.3.3 DYNAMIC DIFFERENTIATORS
             11.3.4 EMERGING COMPANIES
           FIGURE 32 GLOBAL MARKET: COMPETITIVE LEADERSHIP MAPPING (2019)
     11.4 COMPETITIVE SCENARIO
             11.4.1 PRODUCT LAUNCHES
           TABLE 100 PRODUCT LAUNCHES (2017–2020)
             11.4.2 FUNDING
           TABLE 101 FUNDING (2017–2020)
             11.4.3 ACQUISITIONS
           TABLE 102 ACQUISITIONS (2017–2020)
             11.4.4 PARTNERSHIPS
           TABLE 103 PARTNERSHIPS (2017–2020)

12 COMPANY PROFILES (Page No. - 106)
(Business overview, Products offered, Recent developments, MNM view)* 
     12.1 GE HEALTHCARE
           FIGURE 33 GE HEALTHCARE: COMPANY SNAPSHOT
     12.2 MERCK MILLIPORE
           FIGURE 34 MERCK MILLIPORE: COMPANY SNAPSHOT
     12.3 REPLIGEN CORPORATION
           FIGURE 35 REPLIGEN CORPORATION: COMPANY SNAPSHOT (2019)
     12.4 THERMO FISHER SCIENTIFIC, INC.
           FIGURE 36 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
     12.5 TOSOH BIOSCIENCE
           FIGURE 37 TOSOH CORPORATION: COMPANY SNAPSHOT
     12.6 PUROLITE CORPORATION
     12.7 NOVASEP HOLDING SAS
     12.8 AGILENT TECHNOLOGIES, INC.
           FIGURE 38 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
     12.9 GENSCRIPT BIOTECH CORPORATION
           FIGURE 39 GENSCRIPT BIOTECH CORPORATION: COMPANY SNAPSHOT (2018)
     12.10 PERKINELMER, INC.
           FIGURE 40 PERKINELMER, INC.: COMPANY SNAPSHOT
     12.11 BIO-RAD LABORATORIES, INC.
           FIGURE 41 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
     12.12 OROCHEM
     12.13 ANEKA CORPORATION
           FIGURE 42 KANEKA CORPORATION: COMPANY SNAPSHOT
     12.14 ABCAM PLC.
     12.15 AGAROSE BEAD TECHNOLOGIES
     12.16 AVANTOR, INC.
     12.17 JSR LIFE SCIENCES
     12.18 BIO-WORKS TECHNOLOGIES
     12.19 TAKARA BIO
     12.20 GENERON
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies. 

13 APPENDIX (Page No. - 134)
     13.1 DISCUSSION GUIDE
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.3 AVAILABLE CUSTOMIZATIONS
     13.4 RELATED REPORTS
     13.5 AUTHOR DETAILS

The study involved four major activities in estimating the current size for the protein A resin market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as D&B Hoovers, Bloomberg Business, and Factiva have been referred to, to identify and collect information for the global market study. These secondary sources included annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold standard & silver standard websites, regulatory bodies, and databases.

Primary Research

The global market comprises several stakeholders such as chromatography resins manufacturers, pre-packed column manufacturers, government and research organizations, chromatography resins distributors and suppliers, investment banks and private equity firms, and end users such as pharmaceutical and biotechnology companies, universities, and independent research organizations. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. Mentioned below is the breakdown of primary respondents:
Breakdown of Primary Interviews

Protein A Resin Market Size

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the protein A resin market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size-using the market size estimation processes as explained above-the market was split into several segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in protein A resin industry

Report Objectives

  • To define, describe, and forecast the global protein A resin market based on product, type, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to four main regions—North America, Europe, the Asia Pacific, and the Rest of the World (RoW)2
  • To profile the key players and comprehensively analyze their market shares and core competencies3
  • To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements & collaborations, and approvals in the global protein A resin market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the protein A resin market report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the portfolios of the top five companies

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)
Report Code
AST 7818
Published ON
Jan, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Protein A Resin Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2023 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback